Hikma Pharmaceuticals (HKMPF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 3.13B 3.02B 2.88B 2.73B 2.52B 2.55B 2.55B 2.42B
    Cost of Revenue
    		 1.71B 1.57B 1.47B 1.37B 1.25B 1.24B 1.25B 1.17B
    Gross Profit
    		 1.42B 1.45B 1.41B 1.36B 1.26B 1.31B 1.3B 1.25B
    Operating Income
    		 612M 661M 619M 511M 498M 548M 561M 567M
    Interest Income
    		 40M 65M 66M 65M 56M 50M 42M 39M
    Pretax Income
    		 455M 367M 281M 220M 233M 440M 544M 603M
    Net Income
    		 359M 285M 190M 146M 188M 346M 421M 467M
    Selling & General & Admin
    		 662M 651M 632M 606M 601M 585M 561M 509M
    Research & Development
    		 138.54M 146M 149M 139M 144M 153M 143M 134M
    Other Expenses
    		 2.46M 64M n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 803M 993M 1.06B 1.07B 976M 818M 715M 610M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 2.52B 2.56B 2.53B 2.45B 2.23B 2.06B 1.97B 1.78B
    Income Tax Expense
    		 93M 77M 89M 72M 42M 94M 124M 137M
    Shares Outstanding (Basic)
    		 221.85M 223.76M 226.45M 222.03M 220.46M 227.93M 233.97M 231.99M
    Shares Outstanding (Diluted)
    		 223.04M 223.76M 222.74M 222.03M 221.82M 228M 234M 232M
    EPS (Basic)
    		 1.61 1.27 0.85 0.66 0.83 1.50 1.81 2.01
    EPS (Diluted)
    		 1.61 1.27 0.85 0.66 0.83 1.50 1.81 2.01
    EBITDA
    		 787M 844M 791M 730M 670M 768M 718M 653M
    EBIT
    		 608M 712M 619M 511M 498M 548M 561M 567M
    Depreciation & Amortization
    		 179M 132M 172M 219M 172M 220M 157M 86M

    Add to Watchlist